Transcriptional regulation of IL-8 by iron chelator in human epithelial cells is independent from NF-κB but involves ERK1/2-and p38 kinase-dependent activation of AP-1

被引:30
|
作者
Choi, Eun-Young
Park, Zee-Yong
Choi, Eun-Ju
Oh, Hyun-Mee
Lee, SungGa
Choi, Suck-Chei
Lee, Kang-Min
Im, Sin-Hyeog
Chun, Jang-Soo
Jun, Chang-Duk [1 ]
机构
[1] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea
[2] Gwangju Inst Sci & Technol, Res Ctr Biomol Nanotechnol, Kwangju 500712, South Korea
[3] Wonkwang Univ, Sch Med, Digest Dis Res Inst, Iksan, Chonbuk, South Korea
[4] Chonbuk Natl Univ, Div Biol Sci, Coll Nat Sci, Jeonju, Chonbuk, South Korea
关键词
iron chelator; human intestinal epithelial cells; interleukin-8; AP-1; NF-kappa B;
D O I
10.1002/jcb.21367
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have shown that the bacterial iron chelator, deferoxamine (DFO), triggers inflammatory signals including the production of CXC chemokine IL-8, in human intestinal epithelial cells (IECs) by activating the ERK1/2 and p38 kinase pathways. In this study we investigated the mechanisms involved in IL-8 generation by DFO, focusing on the transcription factors involved and the roles of both mitogen-activated protein kinases (MAPKs) in the transcription factor activation. Treatment of human epithelial HT-29 cells with DFO markedly up-regulated the expression of the essential components of the transcription factorAP-1 at a transcriptional level, while it minimally affected the expression of the NF-kappa B subunits. DFO also induced AP-1-dependent transcriptional activity in HT-29 cells, and this activity was further augmented by the wild-type c-jun transfection. In contrast, the AP-1 activity by DFO was markedly decreased by the dominant-negative c-jun transfection. Electrophoretic mobility shift assays revealed that DFO increases the specific binding of AP-1 but not of NF-kappa B. Such AP-1 binding and transcriptional activities were blocked by the inhibitors of the ERK1/2 and p38 kinase pathways, suggesting that both mitogen-activated protein kinases (MAPKs) lie upstream of AP-1. Besides its action on AP-1, DFO also induced the specific binding of other transcription factors such as CREB and Egr-1. In summary, our results indicate that iron chelator-induced IL-8 generation in IECs involves activation of ERK1/2 and p38 kinase and downstream activation of AP-1. A possible link between iron status and two additional transcription factors, that is, CREB and Egr-1, rather than NF-kappa B, was also suggested. J. Cell. Biochem. 102: 1442-1457, 2007. (c) 2007 Wiley-Liss, Inc.
引用
收藏
页码:1442 / 1457
页数:16
相关论文
共 50 条
  • [41] Inhibitors of p38 and ERK1/2 MAPkinase and hydrogen sulphide block constitutive and IL-1β-induced IL-6 and IL-8 expression in the human chondrocyte cell line C-28/I2
    Kloesch, B.
    Liszt, M.
    Steiner, G.
    Broell, J.
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (03) : 729 - 736
  • [42] Roles of ERK and p38 mitogen-activated protein kinases in phorbol ester-induced NF-κB activation and COX-2 expression in human breast epithelial cells
    Kim, Jung-Hwan
    Na, Hye-Kyung
    Pak, Youngmi K.
    Lee, Yun-Sil
    Lee, Su-Jae
    Moon, Aree
    Surh, Young-Joon
    CHEMICO-BIOLOGICAL INTERACTIONS, 2008, 171 (02) : 133 - 141
  • [43] Functional coupling expression of COX-2 and cPLA2 induced by ATP in rat vascular smooth muscle cells: role of ERK1/2, p38 MAPK, and NF-κB
    Lin, Chih-Chung
    Lin, Wei-Ning
    Wang, Wei-Jung
    Sun, Chi-Chin
    Tung, Wei-Hsuan
    Wang, Hui-Hsin
    Yang, Chuen-Mao
    CARDIOVASCULAR RESEARCH, 2009, 82 (03) : 522 - 531
  • [44] Peptide IDR-1002 inhibits NF-κB nuclear Translocation by inhibition of IκBα Degradation and activates p38/ERK1/2-MsK1-Dependent CREB Phosphorylation in Macrophages stimulated with lipopolysaccharide
    Huante-Mendoza, Alejandro
    Silva-Garcia, Octavio
    Oviedo-Boyso, Javier
    Hancock, Robert E. W.
    Baizabal-Aguirre, Victor M.
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [45] SMEAF attenuates the production of pro-inflammatory mediators through the inactivation of Akt-dependent NF-κB, p38 and ERK1/2 pathways in LPS-stimulated BV-2 microglial cells
    Supriady, Hadi
    Kamarudin, Muhamad Noor Alfarizal
    Chan, Chim Kei
    Goh, Bey Hing
    Kadir, Habsah Abdul
    JOURNAL OF FUNCTIONAL FOODS, 2015, 17 : 434 - 448
  • [46] Anti-inflammatory activity of Khayandirobilide A from Khaya senegalensis via NF-κB, AP-1 and p38 MAPK/Nrf2/HO-1 signaling pathways in lipopolysaccharide-stimulated RAW 264.7 and BV-2 cells
    Zhou, Miao-Miao
    Zhang, Wen-Yan
    Li, Rui-Jun
    Guo, Chao
    Wei, Shan-Shan
    Tian, Xiao-Meng
    Luo, Jun
    Kong, Ling-Yi
    PHYTOMEDICINE, 2018, 42 : 152 - 163
  • [47] P38 Kinase, SGK1 and NF-κB Dependent Up-Regulation of Na+/Ca2+ Exchanger Expression and Activity Following TGFβ1 Treatment of Megakaryocytes
    Al-Maghout, Tamer
    Pelzl, Lisann
    Sahu, Itishri
    Sukkar, Basnna
    Hosseinzadeh, Zohreh
    Gutti, Ravi
    Laufer, Stefan
    Voelkl, Jakob
    Pieske, Burkert
    Gawaz, Meinrad
    Lang, Florian
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 42 (06) : 2169 - 2181
  • [48] Interleukin-5 enhances the migration and invasion of bladder cancer cells via ERK1/2-mediated MMP-9/NF-κB/AP-1 pathway: Involvement of the p21WAF1 expression
    Lee, Eo-Jin
    Lee, Se-Jung
    Kim, Sangtae
    Cho, Seok-Cheol
    Choi, Yung Hyun
    Kim, Wun-Jae
    Moon, Sung-Kwon
    CELLULAR SIGNALLING, 2013, 25 (10) : 2025 - 2038
  • [49] Andrographolide Antagonizes INF-α-Induced IL-8 via Inhibition of NADPH Oxidase/ROS/NF-κB and Src/MAPKs/AP-1 Axis in Human Colorectal Cancer HCT116 Cells
    Yuan, Miaomiao
    Meng, Wei
    Liao, Wenzhen
    Lian, Sen
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2018, 66 (20) : 5139 - 5148
  • [50] Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-κB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines
    Bancroft, CC
    Chen, Z
    Yeh, J
    Sunwoo, JB
    Yeh, NT
    Jackson, S
    Jackson, C
    Van Waes, C
    INTERNATIONAL JOURNAL OF CANCER, 2002, 99 (04) : 538 - 548